Danaher Snaps Up Masimo in $9.9B Medical Tech Mega-Deal
Danaher is buying medical tech firm Masimo for $9.9 billion, paying a hefty 40% premium over recent share prices.
Danaher just inked a massive deal to acquire medical technology company Masimo in a transaction valued at roughly $9.9 billion.
The price tag comes out to $180 per share — representing a nearly 40% premium over Masimo's closing price on February 13. That's a serious payday for Masimo shareholders.
The deal is expected to close in the second half of 2026, giving both companies plenty of runway to navigate regulatory approvals and integration planning.
Danaher, already a heavyweight in the life sciences and diagnostics space, is doubling down on medical technology with this acquisition. Masimo is well known for its non-invasive patient monitoring solutions, making it a strategic fit for Danaher's healthcare portfolio.
At nearly $10 billion, this ranks among the larger medtech acquisitions in recent memory.